Giuseppe Schepisi

1.5k total citations
67 papers, 960 citations indexed

About

Giuseppe Schepisi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Giuseppe Schepisi has authored 67 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pulmonary and Respiratory Medicine, 27 papers in Oncology and 21 papers in Cancer Research. Recurrent topics in Giuseppe Schepisi's work include Prostate Cancer Treatment and Research (36 papers), Radiopharmaceutical Chemistry and Applications (13 papers) and Testicular diseases and treatments (12 papers). Giuseppe Schepisi is often cited by papers focused on Prostate Cancer Treatment and Research (36 papers), Radiopharmaceutical Chemistry and Applications (13 papers) and Testicular diseases and treatments (12 papers). Giuseppe Schepisi collaborates with scholars based in Italy, United Kingdom and Slovakia. Giuseppe Schepisi's co-authors include Ugo De Giorgi, Cristian Lolli, Vincenza Conteduca, Chiara Casadei, Giorgia Gurioli, Cecilia Menna, Alberto Farolfi, Maria Concetta Cursano, Daniele Santini and Emanuela Scarpi and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Giuseppe Schepisi

64 papers receiving 958 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giuseppe Schepisi Italy 18 441 361 289 264 196 67 960
Chiara Casadei Italy 17 302 0.7× 319 0.9× 256 0.9× 164 0.6× 187 1.0× 65 787
Elena Verri Italy 17 551 1.2× 711 2.0× 324 1.1× 407 1.5× 156 0.8× 55 1.2k
Roberto Carmagnani Pestana United States 17 279 0.6× 547 1.5× 217 0.8× 192 0.7× 133 0.7× 52 1.1k
Mimma Rizzo Italy 17 696 1.6× 428 1.2× 484 1.7× 333 1.3× 97 0.5× 78 1.1k
Ciara C. O’Sullivan United States 18 262 0.6× 590 1.6× 293 1.0× 299 1.1× 117 0.6× 72 1.0k
Alberto Farolfi Italy 19 321 0.7× 614 1.7× 250 0.9× 206 0.8× 96 0.5× 61 1.0k
Roberta Maltoni Italy 21 299 0.7× 722 2.0× 338 1.2× 376 1.4× 89 0.5× 84 1.2k
Javier Puente Spain 18 639 1.4× 786 2.2× 424 1.5× 426 1.6× 320 1.6× 164 1.5k
Terukazu Nakamura Japan 19 368 0.8× 348 1.0× 568 2.0× 211 0.8× 213 1.1× 70 1.3k
Christoph Seidel Germany 22 542 1.2× 309 0.9× 575 2.0× 298 1.1× 386 2.0× 70 1.2k

Countries citing papers authored by Giuseppe Schepisi

Since Specialization
Citations

This map shows the geographic impact of Giuseppe Schepisi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Schepisi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Schepisi more than expected).

Fields of papers citing papers by Giuseppe Schepisi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Schepisi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Schepisi. The network helps show where Giuseppe Schepisi may publish in the future.

Co-authorship network of co-authors of Giuseppe Schepisi

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Schepisi. A scholar is included among the top collaborators of Giuseppe Schepisi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Schepisi. Giuseppe Schepisi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Conteduca, Vincenza, Emanuela Scarpi, Alice S. Rossi, et al.. (2025). Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer. The Oncologist. 30(5). 1 indexed citations
2.
Giunta, Emilio Francesco, Giuseppe Schepisi, Nicole Brighi, et al.. (2024). An evaluation of talazoparib plus enzalutamide for the treatment of metastatic castration-resistant prostate cancer. Expert Review of Anticancer Therapy. 24(12). 1221–1227. 1 indexed citations
3.
Schepisi, Giuseppe, Caterina Gianni, Michela Palleschi, et al.. (2023). The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer. Cancers. 15(5). 1597–1597. 31 indexed citations
4.
Conteduca, Vincenza, Nicole Brighi, Giuseppe Schepisi, & Ugo De Giorgi. (2023). Immunogenomic profiles associated with response to life-prolonging agents in prostate cancer. British Journal of Cancer. 129(7). 1050–1060. 2 indexed citations
5.
Conteduca, Vincenza, Chiara Casadei, Emanuela Scarpi, et al.. (2022). Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide. Cancers. 14(9). 2219–2219. 8 indexed citations
6.
Conteduca, Vincenza, Emanuela Scarpi, Daniel Wetterskog, et al.. (2021). Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration‐resistant cancer patients. International Journal of Cancer. 150(7). 1166–1173. 7 indexed citations
7.
8.
Urbini, Milena, Giuseppe Schepisi, Caterina Gianni, et al.. (2021). Primary Mediastinal and Testicular Germ Cell Tumors in Adolescents and Adults: A Comparison of Genomic Alterations and Clinical Implications. Cancers. 13(20). 5223–5223. 10 indexed citations
9.
Re, Marzia Del, Vincenza Conteduca, Stefania Crucitta, et al.. (2021). Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide. Prostate Cancer and Prostatic Diseases. 24(2). 524–531. 43 indexed citations
10.
Conteduca, Vincenza, Emanuela Scarpi, Paola Caroli, et al.. (2021). Combining liquid biopsy and functional imaging analysis in metastatic castration‐resistant prostate cancer helps predict treatment outcome. Molecular Oncology. 16(2). 538–548. 10 indexed citations
11.
Schepisi, Giuseppe, Caterina Gianni, Silvia De Padova, et al.. (2021). Vitamin D Deficiency in Testicular Cancer Survivors: A Systematic Review. International Journal of Molecular Sciences. 22(10). 5145–5145. 2 indexed citations
12.
Conteduca, Vincenza, Daniel Wetterskog, Emanuela Scarpi, et al.. (2020). Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer. British Journal of Cancer. 123(6). 982–987. 27 indexed citations
13.
Brighi, Nicole, Vincenza Conteduca, Cristian Lolli, et al.. (2020). The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives. Critical Reviews in Oncology/Hematology. 157. 103199–103199. 18 indexed citations
14.
Brighi, Nicole, Alberto Farolfi, Vincenza Conteduca, et al.. (2019). The Interplay between Inflammation, Anti-Angiogenic Agents, and Immune Checkpoint Inhibitors: Perspectives for Renal Cell Cancer Treatment. Cancers. 11(12). 1935–1935. 20 indexed citations
15.
Lolli, Cristian, Delia De Lisi, Vincenza Conteduca, et al.. (2019). Testosterone levels and androgen receptor copy number variations in castration‐resistant prostate cancer treated with abiraterone or enzalutamide. The Prostate. 79(11). 1211–1220. 16 indexed citations
16.
Conteduca, Vincenza, Giorgia Gurioli, Nicole Brighi, et al.. (2019). Plasma Androgen Receptor in Prostate Cancer. Cancers. 11(11). 1719–1719. 16 indexed citations
17.
Conteduca, Vincenza, Giorgia Gurioli, Lorena Rossi, et al.. (2018). Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer. BMC Cancer. 18(1). 1267–1267. 13 indexed citations
18.
Conteduca, Vincenza, Orazio Caffo, Luca Galli, et al.. (2018). Association among metabolic syndrome, inflammation, and survival in prostate cancer. Urologic Oncology Seminars and Original Investigations. 36(5). 240.e1–240.e11. 20 indexed citations
19.
Conteduca, Vincenza, Orazio Caffo, Cristian Lolli, et al.. (2017). Long‐term clinical impact of PSA surge in castration‐resistant prostate cancer patients treated with abiraterone. The Prostate. 77(9). 1012–1019. 7 indexed citations
20.
Schepisi, Giuseppe, Alberto Farolfi, Vincenza Conteduca, et al.. (2017). Immunotherapy for Prostate Cancer: Where We Are Headed. International Journal of Molecular Sciences. 18(12). 2627–2627. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiara Casadei Breakdown of academic impact, for papers by Elena Verri Breakdown of academic impact, for papers by Roberto Carmagnani Pestana Breakdown of academic impact, for papers by Mimma Rizzo Breakdown of academic impact, for papers by Ciara C. O’Sullivan Breakdown of academic impact, for papers by Alberto Farolfi Breakdown of academic impact, for papers by Roberta Maltoni Breakdown of academic impact, for papers by Javier Puente Breakdown of academic impact, for papers by Terukazu Nakamura Breakdown of academic impact, for papers by Christoph Seidel
Rankless by CCL
2026